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Introduction
3-MEthylGlutaconic aciduria, Deafness, Encephalopathy,
Leigh-like (MEGDEL) syndrome (MIM #614739) or SERAC1
defect is one of the several inborn errors of metabolism
with 3-methylglutaconic aciduria (3-MGA-uria) as a
discriminative feature, a heterogeneous group of disor-
ders.1–5 Here, we expand the clinical and genetic spectrum
by describing one individual early magnetic resonance
imaging (MRI) Leigh syndrome and without hearing










Abstract 3-MEthylGlutaconic aciduria, Deafness, Encephalopathy, neuroradiological evidence of
Leigh-like disease (MEGDEL syndrome) was initially described in four children with
additional features of defective oxidative phosphorylation. Loss of functional variants
in the SERAC1 gene was later reported in relation with this disorder of phospholipid
remodeling. We describe a girl born after a pregnancy complicated by intrauterine
growth retardation. In the neonatal period, she presented hypotonia, lethargy, weak
reﬂexes, transient hypoglycemia, and elevated transaminases. Magnetic resonance
imaging (MRI) performed at 12 days of life showed bilateral basal ganglia alterations
suggestive of Leigh syndrome. She progressed with failure to thrive, severe delay of
developmental milestones, axial hypotonia, spastic tetraparesis and dystonic move-
ments. Investigations disclosed hyperlactacidemia, and the urinary organic acids
revealed high levels mainly of 3-methylglutaconic acid. Muscle biopsy showed de-
creased activity of several complexes of the respiratory chain. Compound hetero-
zygosity for two previously unreported variants in SERAC1 leads to the diagnosis of
MEGDEL syndrome. Unlike other patients, this child presents very early MRI alterations
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This girl was born by cesarean delivery at 39 weeks of
unrelated parents of European ancestry. No relevant familial
clinical history was reported. Despite intrauterine growth
retardation, the pregnancy was uneventful. Her birth weight
was 2,240 g, height 44.5 cm, and head circumference 31.5 cm
(all below p3). Apgar score was 9 and 10 at 1 and 5 minutes,
respectively. After 30 minutes of birth, she started grunting,
showing irritability, decreased reﬂexes, and drowsiness. She
needed parenteral nutrition due to progressive feeding dif-
ﬁculties and progressed to hypotonia and lethargy.
Transienthypoglycemia (1.4mmol/L; referencevalues [RV]:
3.5–5.6) and mildly elevated transaminases were detected.
Blood gas analysis at 48 hours of life revealed metabolic
acidosis (pH 7.15, bicarbonate 10.3 mmol/L) and increased
lactate (6.5 mmol/L; RV: 0.9–2.3). There was no evidence of
infection. She was treated with bicarbonate, antibiotics, and
artiﬁcial ventilation on day 3 of life. Due to worsening of
symptoms on day 4 of life, with constant groaning, breathing
difﬁculty, abdominal distension, food refusal, abundant
brownish secretions in the gastric aspirate, and worsening of
consciousness level to coma, she was transferred to the
neonatal intensive care unit of a specialized metabolic center.
She was pale, not well perfused, mildly jaundiced, pre-
senting groaning, few active movements, slow reactions to
stimuli, decreased neurological reﬂexes, and no peripheral
hypotonia or clonus and rapidly progressed to coma. She did
not present dysmorphisms or hepatomegaly. The electro-
encephalogram revealed depressed, irregular, and moder-
ately reactive features, abundant multifocal paroxysmal
activity and several electrographic seizures. The computed
tomography scan suggested diffuse cerebral edema.
From day 7 of life onwards, she presented progressive
improvement of her neurological status with an increase in
consciousness and reﬂexes despite persistent lactic acidemia
(3.1 mmol/L) and hyperammonemia (182.8 μmol/L; RV:
< 50), without hypoglycemia. Urinary organic acids showed
3-MGA-uria (107 μmol/mmolCr; RV: 0–9, ►Table 1).
MRI of the brain was performed on day 12 of life (►Fig. 1)
and revealed symmetric bilateral lesions involving the
caudate nucleus, the pallidum, and the interior part of the
putamen, white matter hyperintensities on T2 and hypoin-
tense on T1, with pallidal lesions with restricted diffusion. A
high lactate peak at the basal ganglia, pulvinar thalamus, and
white matter was also observed.
Follow-up of the child showed marked failure to thrive,
severe delay of developmental milestones, microcephaly,
spastic tetraparesis, and dystonia. Later sleeping distur-
bances were frequently reported, and at the age of 6 years,
the ﬁrst seizure suggested myoclonic epilepsy, which was
successfully treated with levetiracetam.
Ophthalmological observation and hearing screening
were unremarkable. No follow-up MRI is available.
A muscle biopsy performed at the age of 1 year showed:
ﬁber size variability, overload of periodic acid-Schiff-positive
material in some ﬁbers; cytochrome oxidase/succinic dehy-
drogenase (COX/SDH) staining hyperchromatic aggregates to
the periphery and the absence of COX-negative ﬁbers. The
activity of the respiratory chain showed decreased activity of
several complexes: II (37.9%), IV (34.0%), V (20.1%), and
segment II þ III (23.2%).
A leucine-loading test was performed as described by
Wortmann et al.9 No signiﬁcant increase in 3-MGA-uria was
seen after leucine loading, virtually excluding 3-methylglu-
taconyl-CoA hydratase deﬁciency (AUH) defect (►Table 1).
Sanger Sequencing of SERAC1 gene revealed two pre-
viously unreported variants c.310A > T (p.Lys104) and
c.609 þ 5_609 þ 8del suggesting the diagnosis of MEGDEL
syndrome.
Presently, at the age of 8 years, the patient can ﬁxate and
follow, is interested in her surroundings, smiles, reacts to her
name or other sounds, babbles, looks for hidden objects,
shows difﬁculties in manipulation, but throws toys to the
ﬂoor. Although head control is still unstable, she can roll but
not sit unaided. She has sleeping problems such as difﬁculty
to fall asleep and frequent awakening during the night. Eye
movements are normal, but she also presents myoclonic
epilepsy, frequent dystonic movements of limbs and head
and marked spastic tetraparesis.
Discussion
Since MEGDEL syndrome was ﬁrst described,2 more than 25
cases have been reported. These patients share a strikingly
homogenous clinical phenotype, with signs and symptoms
beginning during their newborn period or infancy.3,6–8,10,11
These include elevated urinary 3-MGA, deafness, neurora-
diological evidence of Leigh-like disease,12 neonatal hypo-
glycemia, bilateral optic nerve atrophy, microcephaly,
myoclonic epilepsy, dystonia, and disturbed oxidative phos-
phorylation. In addition, transient hepatic involvement has
Table 1 Biochemical analysis of urinary organic acids during neonatal period and leucine loading test
Reference value μmol/mmolCr 6 d of life Leucine loading test
Basal After 1 h After 24 h
3-hydroxyisovaleric acid 0–18 66 33 86 130
3-methylglutaric acid 0–0.1 15 28 24 33
3-methylglutaconic acid 0–9 107 187 179 234
3-hydroxy-3-methylglutaric acid 15–43 98 35 39 26
Abbreviation: Cr, creatinine.
Note: Loading test with 100 mg/kg of leucine orally reveals only a 1.25 increase of 3-MGA excluding an AUH defect.
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been described leading to a possible designation of MEGDEL
syndrome.11
Here, we report a case of MEGDEL syndrome, with very
early MRI alterations, already detected 12 days after birth.
This is much earlier than what has been reported for MRI
alterations in MEGDEL syndrome.11
Another important ﬁnding is that this patient displays no
deafness at the age of 8 years. This has only been reported
once in this disorder and we cannot exclude that this will
develop later in life.7
Both variants in SERAC1 detected in this affected indivi-
dual have not been described previously, but prediction
models (Alamut Visual software v.2.7.1) support their patho-
genicity. The nonsense variant c.310A > T (p.Lys104) is
predicted to interrupt the reading frame by a premature
stop codon, which may lead to an impairment in the target-
ing of the producedmRNA for nonsense-mediated decay. The
intronic c.609 þ 5_609 þ 8del variant, also classiﬁed as a
variant of unknownpathogenicity, is close to the donor splice
site of exon 7 and therefore a skip of exon 7 is predicted.
In conclusion, the individual presented here expands the
clinical spectrum with early detectable basal ganglia lesions
and absence of deafness and extends the genetic spectrum.
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Fig. 1 Axial T2-weighted and diffusion MRI images of the brain performed 12 days after birth depicting Leigh-like changes, with (A) bilateral
increased signal change in the caudate nucleus (black arrow), globus pallidus, and medial putamen (arrowhead) and with (B) pallidal lesions with
restricted diffusion (arrows). MRI, magnetic resonance imaging.
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